Apply Now

Eliminating barriers for advancing biomedical science

The Integrated Biomedical Sciences Graduate Program at the University of Notre Dame is a cross-departmental PhD program for research and training in a range of fields in the biomedical sciences. Scientists across the campus, representing 55 different research groups, are organized into thematic Research and Training Clusters that offer students the opportunity to engage in cutting-edge biomedical research that transcends traditional departmental and disciplinary boundaries. Explore our program here, or download a brochure that describes the key aspects.

Recent News

Potential biomarker proves promising for pancreatic cancer diagnostics

Author: Katrina Burgos


When it comes to a cancer diagnosis, timing can be everything. An early diagnosis can make a big difference when it comes to treatment possibilities. Pancreatic Ductile Adenocarcinoma (PDAC) has a 5 year survival rate of 6% according to Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology at the University of Notre Dame. Improving detection rates is a crucial step in changing that statistic. Read more... Read More

Workshop Unites Midwest’s Top Ovarian Cancer Researchers

Author: Michael Rodio

Nearly 50 scientists gathered at the University of Notre Dame on Sunday and Monday for the Indiana-Illinois End Epithelial Ovarian Cancer Coalition (IIEEOCC) workshop, an effort to advance collaboration and research on a deadly form of cancer that affects over 20,000 women a year.   Read more.... Read More

New paper provides important insights into how carcinoma-associated fibroblasts function in breast cancers

Author: William G. Gilroy

Carcinoma-associated fibroblasts (CAFs)

A new paper by a team of researchers led by Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology in the Department of Biological Sciences at the University of Notre Dame, offers important new insights into the role carcinoma-associated fibroblasts (CAFs) play in tumor biology.

A number of recent studies have revealed CAFs to be a major contributor to tumor progression through a variety of mechanisms. Despite this information, the precise role CAFs play in augmenting the growth of tumors is still poorly understood. Read More